{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:08Z","timestamp":1792791428563,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI23\/01590"],"award-info":[{"award-number":["PI23\/01590"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s13555-026-01657-6","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:20:09Z","timestamp":1773933609000},"page":"2393-2410","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications"],"prefix":"10.1007","volume":"16","author":[{"given":"Jes\u00fas","family":"Gay-Mimbrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macarena","family":"Aguilar-Luque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro J.","family":"G\u00f3mez-Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Rivera-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"G\u00f3mez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Juan-Cencerrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Moch\u00f3n-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmeralda","family":"Parra-Peralbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Ruiz-Villaverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Li\u00f1ares-Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Carmona-Saez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Isla-Tejera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0286-4107","authenticated-orcid":false,"given":"Juan","family":"Ruano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"issue":"7","key":"1657_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/genes14071362","volume":"14","author":"CY Ho","year":"2023","unstructured":"Ho CY, Wu CY, Chen JY, Wu CY. Clinical and genetic aspects of alopecia areata: a cutting edge review. Genes. 2023;14(7): 1362. https:\/\/doi.org\/10.3390\/genes14071362.","journal-title":"Genes"},{"key":"1657_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljae058","author":"JJ Jeon","year":"2024","unstructured":"Jeon JJ, Jung SW, Kim YH, et\u00a0al. Global, regional, and national epidemiology of alopecia areata: a systematic review and modelling study. Br J Dermatol. 2024. https:\/\/doi.org\/10.1093\/bjd\/ljae058.","journal-title":"Br J Dermatol"},{"key":"1657_CR3","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2147\/CCID.S445646","volume":"17","author":"A Bewley","year":"2024","unstructured":"Bewley A, Figueras-Nart I, Zhang J, et\u00a0al. Patient-reported burden of severe alopecia areata: first results from the multinational alopecia areata unmet need survey. Clin Cosmet Investig Dermatol. 2024;17:751\u201361. https:\/\/doi.org\/10.2147\/CCID.S445646.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"4","key":"1657_CR4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s13555-022-00711-3","volume":"12","author":"BA King","year":"2022","unstructured":"King BA, Senna MM, Ohyama M, et\u00a0al. Defining severity in alopecia areata: current perspectives and a multidimensional framework. Dermatol Ther (Heidelb). 2022;12(4):825\u201334. https:\/\/doi.org\/10.1007\/s13555-022-00711-3.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"3","key":"1657_CR5","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jaad.2021.05.016","volume":"86","author":"C Dubin","year":"2022","unstructured":"Dubin C, Glickman JW, Del Duca E, et\u00a0al. Scalp and serum profiling of frontal fibrosing alopecia reveals scalp immune and fibrosis dysregulation with no systemic involvement. J Am Acad Dermatol. 2022;86(3):551\u201362. https:\/\/doi.org\/10.1016\/j.jaad.2021.05.016.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"1657_CR6","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1111\/all.14814","volume":"76","author":"JW Glickman","year":"2021","unstructured":"Glickman JW, Dubin C, Dahabreh D, et\u00a0al. An integrated scalp and blood biomarker approach suggests the systemic nature of alopecia areata. Allergy. 2021;76(10):3053\u201365. https:\/\/doi.org\/10.1111\/all.14814.","journal-title":"Allergy"},{"key":"1657_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-024-00620-2","author":"LL Westerkam","year":"2024","unstructured":"Westerkam LL, McShane DB, Nieman EL, Morrell DS. Treatment options for alopecia areata in children and adolescents. Paediatr Drugs. 2024. https:\/\/doi.org\/10.1007\/s40272-024-00620-2.","journal-title":"Paediatr Drugs"},{"issue":"4","key":"1657_CR8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/jdv.19768","volume":"38","author":"L Rudnicka","year":"2024","unstructured":"Rudnicka L, Arenbergerova M, Grimalt R, et\u00a0al. European expert consensus statement on the systemic treatment of alopecia areata. J Eur Acad Dermatol Venereol. 2024;38(4):687\u201394. https:\/\/doi.org\/10.1111\/jdv.19768.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"1657_CR9","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jaad.2016.08.042","volume":"75","author":"EA Olsen","year":"2016","unstructured":"Olsen EA, Canfield D. SALT II: a new take on the severity of alopecia tool (SALT) for determining percentage scalp hair loss. J Am Acad Dermatol. 2016;75(6):1268\u201370. https:\/\/doi.org\/10.1016\/j.jaad.2016.08.042.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1657_CR10","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/bjd.18883","volume":"183","author":"KW Wyrwich","year":"2020","unstructured":"Wyrwich KW, Kitchen H, Knight S, et\u00a0al. The alopecia areata investigator global assessment scale: a measure for evaluating clinically meaningful success in clinical trials. Br J Dermatol. 2020;183(4):702\u20139. https:\/\/doi.org\/10.1111\/bjd.18883.","journal-title":"Br J Dermatol"},{"key":"1657_CR11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ebiom.2016.03.036","volume":"7","author":"A Jabbari","year":"2016","unstructured":"Jabbari A, Cerise JE, Chen JC, et\u00a0al. Molecular signatures define alopecia areata subtypes and transcriptional biomarkers. EBioMedicine. 2016;7:240\u20137. https:\/\/doi.org\/10.1016\/j.ebiom.2016.03.036.","journal-title":"EBioMedicine"},{"issue":"22","key":"1657_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10225418","volume":"10","author":"A Wa\u015bkiel-Burnat","year":"2021","unstructured":"Wa\u015bkiel-Burnat A, Niemczyk A, Blicharz L, et\u00a0al. Chemokine C-C motif ligand 7 (CCL7), a biomarker of atherosclerosis, is associated with the severity of alopecia areata: a preliminary study. J Clin Med. 2021;10(22): 5418. https:\/\/doi.org\/10.3390\/jcm10225418.","journal-title":"J Clin Med"},{"issue":"1","key":"1657_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92853-1","volume":"11","author":"A Stochmal","year":"2021","unstructured":"Stochmal A, Wa\u015bkiel-Burnat A, Chrostowska S, et\u00a0al. Adiponectin as a novel biomarker of disease severity in alopecia areata. Sci Rep. 2021;11(1): 13809. https:\/\/doi.org\/10.1038\/s41598-021-92853-1.","journal-title":"Sci Rep"},{"key":"1657_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268086","author":"A Wa\u015bkiel-Burnat","year":"2022","unstructured":"Wa\u015bkiel-Burnat A, Niemczyk A, Chmieli\u0144ska P, et\u00a0al. Lipocalin-2 and insulin as new biomarkers of alopecia areata. PLoS ONE. 2022. https:\/\/doi.org\/10.1371\/journal.pone.0268086. (Published 2022 May 31).","journal-title":"PLoS ONE"},{"issue":"2","key":"1657_CR15","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1159\/000515764","volume":"238","author":"T Zhang","year":"2022","unstructured":"Zhang T, Nie Y. Prediction of the risk of alopecia areata progressing to alopecia totalis and alopecia universalis: biomarker development with bioinformatics analysis and machine learning. Dermatology. 2022;238(2):386\u201396. https:\/\/doi.org\/10.1159\/000515764.","journal-title":"Dermatology"},{"issue":"4","key":"1657_CR16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/exd.12918","volume":"25","author":"J Fuentes-Duculan","year":"2016","unstructured":"Fuentes-Duculan J, Gulati N, Bonifacio KM, et\u00a0al. Biomarkers of alopecia areata disease activity and response to corticosteroid treatment. Exp Dermatol. 2016;25(4):282\u20136. https:\/\/doi.org\/10.1111\/exd.12918.","journal-title":"Exp Dermatol"},{"issue":"11","key":"1657_CR17","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/1346-8138.12273","volume":"40","author":"S Inui","year":"2013","unstructured":"Inui S, Noguchi F, Nakajima T, Itami S. Serum thymus and activation-regulated chemokine as disease activity and response biomarker in alopecia areata. J Dermatol. 2013;40(11):881\u20135. https:\/\/doi.org\/10.1111\/1346-8138.12273.","journal-title":"J Dermatol"},{"issue":"6","key":"1657_CR18","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1111\/jocd.14473","volume":"21","author":"AI Mustafa","year":"2022","unstructured":"Mustafa AI, Al-Refaie AM, El-Shimi OS, Fawzy E, Sorour NE. Diagnostic implications of MicroRNAs; 155, 146a, and 203 lesional expression in alopecia areata: a preliminary case-controlled study. J Cosmet Dermatol. 2022;21(6):2648\u201354. https:\/\/doi.org\/10.1111\/jocd.14473.","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"1657_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/gene.2017.4","volume":"18","author":"EHC Wang","year":"2017","unstructured":"Wang EHC, DeStefano GM, Patel AV, et\u00a0al. Identification of differentially expressed miRNAs in alopecia areata that target immune-regulatory pathways. Genes Immun. 2017;18(2):100\u20134. https:\/\/doi.org\/10.1038\/gene.2017.4.","journal-title":"Genes Immun"},{"issue":"3","key":"1657_CR20","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jid.2017.09.046","volume":"138","author":"A Tafazzoli","year":"2018","unstructured":"Tafazzoli A, Forstner AJ, Broadley D, et\u00a0al. Genome-wide microRNA analysis implicates miR-30b\/d in the etiology of alopecia areata. J Invest Dermatol. 2018;138(3):549\u201356. https:\/\/doi.org\/10.1016\/j.jid.2017.09.046.","journal-title":"J Invest Dermatol"},{"key":"1657_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-023-02588-4","author":"A Roso-Mares","year":"2024","unstructured":"Roso-Mares A, And\u00fajar I, D\u00edaz Corpas T, Sun BK. Non-coding RNAs as skin disease biomarkers, molecular signatures, and therapeutic targets. Hum Genet. 2024. https:\/\/doi.org\/10.1007\/s00439-023-02588-4.","journal-title":"Hum Genet"},{"issue":"3","key":"1657_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1080\/08916934.2019.1710135","volume":"53","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wu H, Zhao M, Lu Q. Identifying the differentially expressed microRNAs in autoimmunity: a systemic review and meta-analysis. Autoimmunity. 2020;53(3):122\u201336. https:\/\/doi.org\/10.1080\/08916934.2019.1710135.","journal-title":"Autoimmunity"},{"issue":"1","key":"1657_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","volume":"10","author":"JM Hanifin","year":"2001","unstructured":"Hanifin JM, Thurston M, Omoto M, et\u00a0al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Exp Dermatol. 2001;10(1):11\u20138. https:\/\/doi.org\/10.1034\/j.1600-0625.2001.100102.x.","journal-title":"Exp Dermatol"},{"issue":"3","key":"1657_CR24","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/bjd.15665","volume":"177","author":"CH Smith","year":"2017","unstructured":"Smith CH, Jabbar-Lopez ZK, Yiu ZZ, et\u00a0al. British association of dermatologists guidelines for biologic therapy for psoriasis 2017. Br J Dermatol. 2017;177(3):628\u201336. https:\/\/doi.org\/10.1111\/bjd.15665.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1657_CR25","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jaad.2016.10.045","volume":"76","author":"N van Geel","year":"2017","unstructured":"van Geel N, Lommerts J, Bekkenk M, et\u00a0al. Development and validation of a patient-reported outcome measure in vitiligo: the self-assessment vitiligo extent score (SA-VES). J Am Acad Dermatol. 2017;76(3):464\u201371. https:\/\/doi.org\/10.1016\/j.jaad.2016.10.045.","journal-title":"J Am Acad Dermatol"},{"key":"1657_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks487","author":"D Tabas-Madrid","year":"2012","unstructured":"Tabas-Madrid D, Nogales-Cadenas R, Pascual-Montano A. GeneCodis4: a meta-tool for the integration of gene set enrichment and pathway analysis. Nucleic Acids Res. 2012. https:\/\/doi.org\/10.1093\/nar\/gks487.","journal-title":"Nucleic Acids Res"},{"key":"1657_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4924356","author":"N Zhu","year":"2018","unstructured":"Zhu N, Huang K, Liu Y, Zhang H, Lin E, Zeng Y, Li H, Xu Y, Cai B, Yuan Y, Li Y, Lin C. MiR-195-5p regulates hair follicle inductivity of dermal papilla cells by suppressing Wnt\/\u03b2-catenin activation. Biomed Res Int. 2018. https:\/\/doi.org\/10.1155\/2018\/4924356.","journal-title":"Biomed Res Int"},{"key":"1657_CR28","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/j.celrep.2019.10.062","volume":"29","author":"M Ge","year":"2019","unstructured":"Ge M, Liu C, Li L, et\u00a0al. miR-29a\/b1 inhibits hair follicle stem cell lineage progression by spatiotemporally suppressing WNT and BMP signaling. Cell Rep. 2019;29:2489-2504.e4. https:\/\/doi.org\/10.1016\/j.celrep.2019.10.062.","journal-title":"Cell Rep"},{"key":"1657_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.593638","volume":"8","author":"Y Chen","year":"2020","unstructured":"Chen Y, Huang J, Liu Z, et\u00a0al. MiR-140-5p in small extracellular vesicles from human papilla cells stimulates hair growth by promoting proliferation of outer root sheath and hair matrix cells. Front Cell Dev Biol. 2020;8: 593638. https:\/\/doi.org\/10.3389\/fcell.2020.593638.","journal-title":"Front Cell Dev Biol"},{"key":"1657_CR30","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.omtn.2020.11.017","volume":"23","author":"X Feng","year":"2020","unstructured":"Feng X, Zhou S, Cai W, Guo J. The miR-93-3p\/ZFP36L1\/ZFX axis regulates keratinocyte proliferation and migration during skin wound healing. Mol Ther Nucleic Acids. 2020;23:450\u201363. https:\/\/doi.org\/10.1016\/j.omtn.2020.11.017.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1657_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.516","author":"CX Li","year":"2017","unstructured":"Li CX, Li HG, Huang LT, et\u00a0al. H19 lncRNA regulates keratinocyte differentiation by targeting miR-130b-3p. Cell Death Dis. 2017. https:\/\/doi.org\/10.1038\/cddis.2017.516.","journal-title":"Cell Death Dis"},{"key":"1657_CR32","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.3892\/mmr.2014.2886","volume":"11","author":"Z Song","year":"2015","unstructured":"Song Z, Liu D, Peng Y, et\u00a0al. Differential microRNA expression profile comparison between epidermal stem cells and differentiated keratinocytes. Mol Med Rep. 2015;11:2285\u201391. https:\/\/doi.org\/10.3892\/mmr.2014.2886.","journal-title":"Mol Med Rep"},{"key":"1657_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8524972","volume":"2017","author":"JA Li","year":"2017","unstructured":"Li JA, Wang YD, Wang K, et\u00a0al. Downregulation of miR-214-3p may contribute to pathogenesis of ulcerative colitis via targeting STAT6. BioMed Res Int. 2017;2017: 8524972. https:\/\/doi.org\/10.1155\/2017\/8524972.","journal-title":"BioMed Res Int"},{"key":"1657_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105840","volume":"23","author":"V Scalavino","year":"2022","unstructured":"Scalavino V, Piccinno E, Bianco G, et\u00a0al. The increase of miR-195-5p reduces intestinal permeability in ulcerative colitis, modulating tight junctions\u2019 expression. Int J Mol Sci. 2022;23: 5840. https:\/\/doi.org\/10.3390\/ijms23105840.","journal-title":"Int J Mol Sci"},{"key":"1657_CR35","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.18632\/aging.202428","volume":"13","author":"R Zhou","year":"2021","unstructured":"Zhou R, Qiu P, Wang H, et\u00a0al. Identification of microRNA-16-5p and microRNA-21-5p in feces as potential noninvasive biomarkers for inflammatory bowel disease. Aging. 2021;13:4634\u201346. https:\/\/doi.org\/10.18632\/aging.202428.","journal-title":"Aging"},{"key":"1657_CR36","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1080\/08820139.2021.1981930","volume":"51","author":"H Li","year":"2022","unstructured":"Li H, Liu Z, Guo X, Zhang M. Circ_0128846\/miR-140-3p\/JAK2 network in osteoarthritis development. Immunol Invest. 2022;51:1529\u201347. https:\/\/doi.org\/10.1080\/08820139.2021.1981930.","journal-title":"Immunol Invest"},{"key":"1657_CR37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2174\/1566524023666221103161203","volume":"24","author":"W Xie","year":"2024","unstructured":"Xie W, Jiang L, Huang X, et\u00a0al. Hsa_circ_0004662 accelerates the progression of osteoarthritis via the microRNA-424-5p\/VEGFA axis. Curr Mol Med. 2024;24:217\u201325. https:\/\/doi.org\/10.2174\/1566524023666221103161203.","journal-title":"Curr Mol Med"},{"key":"1657_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3203","author":"D Li","year":"2020","unstructured":"Li D, Sun Y, Wan Y, et\u00a0al. LncRNA NEAT1 promotes proliferation of chondrocytes via downregulation of miR-16-5p in osteoarthritis. J Gene Med. 2020. https:\/\/doi.org\/10.1002\/jgm.3203.","journal-title":"J Gene Med"},{"key":"1657_CR39","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1167\/iovs.19-27062","volume":"60","author":"YJ Kim","year":"2019","unstructured":"Kim YJ, Yeon Y, Lee WJ, et\u00a0al. Comparison of microRNA expression in tears of normal subjects and Sj\u00f6gren syndrome patients. Invest Ophthalmol Vis Sci. 2019;60:4889\u201395. https:\/\/doi.org\/10.1167\/iovs.19-27062.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1657_CR40","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/cei.13156","volume":"193","author":"M Dunaeva","year":"2018","unstructured":"Dunaeva M, Blom J, Thurlings R, Pruijn GJM. Circulating serum miR-223-3p and miR-16-5p as possible biomarkers of early rheumatoid arthritis. Clin Exp Immunol. 2018;193:376\u201385. https:\/\/doi.org\/10.1111\/cei.13156.","journal-title":"Clin Exp Immunol"},{"key":"1657_CR41","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s10067-018-4380-z","volume":"38","author":"A Singh","year":"2019","unstructured":"Singh A, Patro PS, Aggarwal A. MicroRNA-132, miR-146a, and miR-155 as potential biomarkers of methotrexate response in patients with rheumatoid arthritis. Clin Rheumatol. 2019;38:877\u201384. https:\/\/doi.org\/10.1007\/s10067-018-4380-z.","journal-title":"Clin Rheumatol"},{"key":"1657_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13018-021-02236-5","volume":"16","author":"B Zu","year":"2021","unstructured":"Zu B, Liu L, Wang J, et\u00a0al. MiR-140-3p inhibits the cell viability and promotes apoptosis of synovial fibroblasts in rheumatoid arthritis through targeting sirtuin 3. J Orthop Surg Res. 2021;16:105. https:\/\/doi.org\/10.1186\/s13018-021-02236-5.","journal-title":"J Orthop Surg Res"},{"key":"1657_CR43","doi-asserted-by":"publisher","first-page":"11624","DOI":"10.1002\/jcb.28442","volume":"120","author":"Y Chen","year":"2019","unstructured":"Chen Y, Wang W, Chen Y, et\u00a0al. Microrna-19a-3p promotes rheumatoid arthritis fibroblast-like synoviocytes via targeting SOCS3. J Cell Biochem. 2019;120:11624\u201332. https:\/\/doi.org\/10.1002\/jcb.28442.","journal-title":"J Cell Biochem"},{"key":"1657_CR44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3390\/diagnostics9030098","volume":"9","author":"CC Tseng","year":"2019","unstructured":"Tseng CC, Wu LY, Tsai WC, et\u00a0al. Differential expression profiles of the transcriptome and miRNA interactome in synovial fibroblasts of rheumatoid arthritis revealed by next generation sequencing. Diagnostics (Basel). 2019;9:98. https:\/\/doi.org\/10.3390\/diagnostics9030098.","journal-title":"Diagnostics (Basel)"},{"key":"1657_CR45","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.21037\/atm-21-4939","volume":"9","author":"B Li","year":"2021","unstructured":"Li B, Zhang Z, Fu Y. Anti-inflammatory effects of artesunate on atherosclerosis via miR-16-5p and TXNIP regulation of the NLRP3 inflammasome. Ann Transl Med. 2021;9:1558. https:\/\/doi.org\/10.21037\/atm-21-4939.","journal-title":"Ann Transl Med"},{"key":"1657_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119464","volume":"277","author":"Y Pu","year":"2021","unstructured":"Pu Y, Zhao Q, Men X, et\u00a0al. Microrna-325 facilitates atherosclerosis progression by mediating the SREBF1\/LXR axis via KDM1A. Life Sci. 2021;277: 119464. https:\/\/doi.org\/10.1016\/j.lfs.2021.119464.","journal-title":"Life Sci"},{"key":"1657_CR47","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00444.2019","author":"Q Su","year":"2020","unstructured":"Su Q, Liu Y, Lv XW, et\u00a0al. LncRNA TUG1 mediates ischemic myocardial injury by targeting miR-132-3p\/HDAC3 axis. Am J Physiol Heart Circ Physiol. 2020. https:\/\/doi.org\/10.1152\/ajpheart.00444.2019.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1657_CR48","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.nut.2015.06.008","volume":"32","author":"JL Marques","year":"2016","unstructured":"Marques JL, Milagro FI, Mansego ML, et\u00a0al. Expression of inflammation-related miRNAs in white blood cells from subjects with metabolic syndrome after 8 wk of following a Mediterranean diet-based weight loss program. Nutrition. 2016;32:48\u201355. https:\/\/doi.org\/10.1016\/j.nut.2015.06.008.","journal-title":"Nutrition"},{"key":"1657_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184256","author":"XD Li","year":"2017","unstructured":"Li XD, Yang YJ, Wang LY, et\u00a0al. Elevated plasma miRNA-122, -140-3p, -720, -2861, and -3149 during early period of acute coronary syndrome are derived from peripheral blood mononuclear cells. PLoS ONE. 2017. https:\/\/doi.org\/10.1371\/journal.pone.0184256.","journal-title":"PLoS ONE"},{"key":"1657_CR50","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.2147\/DDDT.S248104","volume":"14","author":"ZJ Chen","year":"2020","unstructured":"Chen ZJ, Zhao XS, Fan TP, et\u00a0al. Glycine improves ischemic stroke through miR-19a-3p\/AMPK\/GSK-3\u03b2\/HO-1 pathway. Drug Des Devel Ther. 2020;14:2021\u201331. https:\/\/doi.org\/10.2147\/DDDT.S248104.","journal-title":"Drug Des Devel Ther"},{"key":"1657_CR51","doi-asserted-by":"publisher","first-page":"22843","DOI":"10.18632\/aging.203578","volume":"13","author":"M Liu","year":"2021","unstructured":"Liu M, Yang P, Fu D, et\u00a0al. Allicin protects against myocardial I\/R by accelerating angiogenesis via the miR-19a-3p\/PI3K\/AKT axis. Aging (Albany NY). 2021;13:22843\u201355. https:\/\/doi.org\/10.18632\/aging.203578.","journal-title":"Aging (Albany NY)"},{"key":"1657_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115637","volume":"426","author":"M Sun","year":"2021","unstructured":"Sun M, Guo M, Ma G, et\u00a0al. Microrna-30c-5p protects against myocardial ischemia\/reperfusion injury via regulation of Bach1\/Nrf2. Toxicol Appl Pharmacol. 2021;426: 115637. https:\/\/doi.org\/10.1016\/j.taap.2021.115637.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1657_CR53","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1016\/j.bbrc.2018.08.049","volume":"503","author":"P Li","year":"2018","unstructured":"Li P, Zhong X, Li J, et\u00a0al. Microrna-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis. Biochem Biophys Res Commun. 2018;503:2833\u201340. https:\/\/doi.org\/10.1016\/j.bbrc.2018.08.049.","journal-title":"Biochem Biophys Res Commun"},{"key":"1657_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2020.106782","volume":"135","author":"H Yu","year":"2020","unstructured":"Yu H, Zhao L, Zhao Y, et\u00a0al. Circular RNA circ_0029589 regulates proliferation, migration, invasion, and apoptosis in ox-LDL-stimulated VSMCs by regulating miR-424-5p\/IGF2 axis. Vascul Pharmacol. 2020;135: 106782. https:\/\/doi.org\/10.1016\/j.vph.2020.106782.","journal-title":"Vascul Pharmacol"},{"key":"1657_CR55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.nut.2015.06.008","volume":"32","author":"JL Marques","year":"2016","unstructured":"Marques JL, Milagro FI, Mansego ML, et\u00a0al. Expression of inflammation-related miRNAs in white blood cells from subjects with metabolic syndrome after 8 weeks of following a Mediterranean diet-based weight loss program. Nutrition. 2016;32:48\u201355. https:\/\/doi.org\/10.1016\/j.nut.2015.06.008.","journal-title":"Nutrition"},{"key":"1657_CR56","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s13555-023-00937-9","volume":"13","author":"P George","year":"2023","unstructured":"George P, Jagun O, Liu Q, et\u00a0al. Incidence rates of infections, malignancies, thromboembolism, and cardiovascular events in an alopecia areata cohort from a US claims database. Dermatol Ther (Heidelb). 2023;13:1733\u201346.","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01657-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01657-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01657-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:18:32Z","timestamp":1779949112000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01657-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1657"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01657-6","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Juan Ruano is an Editorial Board member of Dermatology and Therapy. Juan Ruano was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Jes\u00fas Gay-Mimbrera, Macarena Aguilar-Luque, Pedro Jes\u00fas G\u00f3mez-Arias, Irene Rivera-Ruiz, Francisco G\u00f3mez-Garc\u00eda, Miguel Juan-Cencerrado, Carmen Moch\u00f3n-Jim\u00e9nez, Esmeralda Parra-Peralbo, Ricardo Ruiz-Villaverde,\u00a0Jos\u00e9 Li\u00f1ares-Blanco, Pedro Carmona-Saez, and Beatriz Isla-Tejera declare that they have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the Provincial Research Ethics Committee of C\u00f3rdoba, Spain (approval number HRP-503). This research was conducted in accordance with the principles of the Declaration of Helsinki (1975, revised 1983), the Belmont Report, and national and European regulations on clinical research and data protection. Written informed consent was obtained from all participants, including consent for study participation and for future use of their anonymized data in scientific publications.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}